Author:
Zahlten-Hinguranage A,Goldschmidt H,Cremer F W,Egerer G,Moehler T,Witte D,Bernd L,Sabo D,Zeifang F
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Alexandrakis MG, Passam FH, Sfiridaki A, Kandidaki E, Roussou P, Kyriakou DS (2003) Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity. Am J Hematol 72: 229–233
2. Bataille R, Boccadoro M, Klein B, Durie B, Pileri A (1992) C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 80: 733–737
3. Berenson JR (2005) Myeloma bone disease. Best Pract Res Clin Haematol 18: 653–672
4. Biro L, Domjan G, Falus A, Jakab L, Cseh K, Kalabay L, Tarkovacs G, Tresch J, Malless E, Kramer J, Prohaszka Z, Jako J, Füst G, Csaszar A (1998) Cytokine regulation of the acute-phase protein levels in multiple myeloma. Eur J Clin Invest 28: 679–686
5. Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoror M, Child JA, Comenzo R, Djulbegovic B, Fantl D, Gaharton G, Harousseau JL, Hungria V, Joshua D, Ludwig H, Mehta J, Morales AR, Morgan G, Nouel A, Okel M, Powles R, Roodman D, San Miguel J, Shimizu K, Singhal S, Sirohi B, Sonneveld P, Tricot G, Van Ness B (2003) Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol 4: 379–398
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献